NOS3 and heart failure: Most studies investigating the effects of β3-AR agonists in heart failure demonstrated that β3-AR agonists attenuated cardiac hypertrophy and fibrosis and improved cardiac contractility via coupling of β3-AR to the eNOS/cGMP pathway as the main mechanism14,52.